Ellen Bjurgert - Coloplast Vice Relations
| 0QBO Stock | 886.80 11.35 1.30% |
Executive
Ellen Bjurgert is Vice Relations of Coloplast AS
| Address | Holtedam 1-3, Humlebæk, Denmark, 3050 |
| Phone | 45 49 11 11 11 |
| Web | https://www.coloplast.com |
Coloplast Management Efficiency
The company has return on total asset (ROA) of 0.0949 % which means that it generated a profit of $0.0949 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2867 %, meaning that it generated $0.2867 on every $100 dollars invested by stockholders. Coloplast's management efficiency ratios could be used to measure how well Coloplast manages its routine affairs as well as how well it operates its assets and liabilities. Intangible Assets is likely to gain to about 2 B in 2024, whereas Total Assets are likely to drop slightly above 14.5 B in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| CFA CFA | New Residential Investment | 52 | |
| Scott Toland | Zurich Insurance Group | N/A | |
| Nicole Yates | Zurich Insurance Group | N/A | |
| Francesca Stacchiotti | Infrastrutture Wireless Italian | 50 | |
| S ACII | Ecclesiastical Insurance Office | N/A | |
| BComm BCom | Ecclesiastical Insurance Office | N/A | |
| Stephane Baj | Zurich Insurance Group | N/A | |
| Satish Mansukhani | New Residential Investment | N/A | |
| Fabio Ruffini | Infrastrutture Wireless Italian | N/A | |
| Ian Thompson | Zurich Insurance Group | N/A | |
| Claudia Cordioli | Zurich Insurance Group | N/A | |
| Chip Ohlsson | Wyndham Hotels Resorts | N/A | |
| Scott Strickland | Wyndham Hotels Resorts | 53 | |
| Steve Collinson | Zurich Insurance Group | N/A | |
| Shilpan Patel | Wyndham Hotels Resorts | N/A | |
| Peter Giger | Zurich Insurance Group | 60 | |
| Lewis Fader | InterContinental Hotels Group | N/A | |
| David Moore | Ecclesiastical Insurance Office | N/A | |
| R FCIS | Ecclesiastical Insurance Office | N/A | |
| Matt Capuzzi | Wyndham Hotels Resorts | N/A | |
| Lisa Checchio | Wyndham Hotels Resorts | 43 | |
Management Performance
| Return On Equity | 0.29 | ||||
| Return On Asset | 0.0949 |
Coloplast AS Leadership Team
Elected by the shareholders, the Coloplast's board of directors comprises two types of representatives: Coloplast inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Coloplast. The board's role is to monitor Coloplast's management team and ensure that shareholders' interests are well served. Coloplast's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Coloplast's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ellen Bjurgert, Vice Relations | ||
| Allan Rasmussen, Executive Operations | ||
| Alain Morvan, Senior Europe | ||
| Nicolai Andersen, Executive Innovation | ||
| Thomas Barfod, Controller Director | ||
| Kristian Villumsen, President CEO | ||
| Dennis Kaysen, Director Communications | ||
| Rasmus Mller, Senior Care | ||
| Anders LonningSkovgaard, Executive CFO | ||
| Aleksandra Dimovska, Vice Relations | ||
| Caroline Rosenstand, Executive Care | ||
| Paul Marcun, Executive Growth | ||
| Dorthe Ronnau, Executive Culture |
Coloplast Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Coloplast a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.29 | ||||
| Return On Asset | 0.0949 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 222.57 B | ||||
| Shares Owned By Insiders | 35.00 % | ||||
| Shares Owned By Institutions | 30.46 % | ||||
| Revenue | 27.03 B | ||||
| Gross Profit | 15.53 B | ||||
| EBITDA | 8.19 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Coloplast Stock Analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.